A BS including molecules involved in the TCR signaling pathway proved to be an independent prognostic factor of poor outcome in a multivariate analysis, specifically in PTCL-NOS patients.
However, although some studies have reported biomarkers of different grades of glioma [ 34, 35], investigations showing the prognosis value of molecular factors by multivariate analysis, specifically in the GBM subgroup, have been limited, and most used semi-quantitative methods or mRNA analysis [ 36, 37].
These data support that the deciding factor for prolonged shedding was, in fact, the presence of pneumonia; however, due to the small number of cases, it was not possible to apply a multivariate analysis to specifically address this point.
As far as the authors can ascertain, this is the first study, using the standardized test described by the European multicenter study [ 33] and multivariate analysis, aimed specifically at evaluating mHLA-DR expression in a cohort of severe trauma patients.
Multivariate statistical analysis, specifically principle component analysis (PCA), was utilized in order to provide a direct link between the fingerprint behavior and the starting network structure.
Specifically, multivariate analysis is applied to data on a wide variety of stakeholders' policy beliefs and policy preferences to identify the policy dimensions that characterize the debate over energy policy in the United States.
Specifically, multivariate analysis revealed age, grade and PgR negativity as the independent factors distinguishing BRCA1 tumours from familial non- BRCA1/2 tumours.
Specifically, multivariate analysis identified urinary tract as focus of infection as the most important independent factor associated with a higher risk of spontaneous gram-negative bacilli meningitis.
Specifically, multivariate analysis showed that pathway signature was associated with DFS (adjusted Hazard Ratio: 2.04, 95% C.I. 1.1 3.78) and OS (adjusted Hazard Ratio: 2.2, 95% C.I. 1.05 4.57), while time-course signature was associated with DFS (adjusted Hazard Ratio: 2.52, 95% C.I. 1.36 4.67) and OS (adjusted Hazard Ratio: 1.96, 95% C.I. 0.92 4.2).
The differences in the cancer screening rates will be examined with both multivariate regression methods and survival analysis, specifically to adjust for withdrawal and right censoring over the study period.
The effect of β-blockers and calcium-channel blockers was tested specifically by multivariate analysis and was not significantly related to frequent nocturnal sweating (data not shown).
